Michael J. Yang
CIK: 0001702283
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (9 total)
- Jul 1, 2026IONS
IONIS PHARMACEUTICALS INC
Award(A)DirectNon-Qualified Stock Option (right to buy)
5.4K shares- - Jul 1, 2026IONS
IONIS PHARMACEUTICALS INC
Award(A)DirectRestricted Stock Unit
2.3K shares- - Jun 10, 2026PCRX
Pacira BioSciences, Inc.
Award(A)Direct6.4K shares- - Jan 15, 2026IONS
IONIS PHARMACEUTICALS INC
Exercise(M)Direct1.9K shares- - Jul 15, 2025IONS
IONIS PHARMACEUTICALS INC
Exercise(M)Direct4.1K shares- - Jul 1, 2025IONS
IONIS PHARMACEUTICALS INC
Award(A)DirectNon-Qualified Stock Option (right to buy)
11.5K shares- - Jul 1, 2025IONS
IONIS PHARMACEUTICALS INC
Award(A)DirectRestricted Stock Unit
5.2K shares- - Jun 11, 2025PCRX
Pacira BioSciences, Inc.
Award(A)Direct6.2K shares- - Jan 15, 2025IONS
IONIS PHARMACEUTICALS INC
Exercise(M)Direct1.9K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 1, 2026 |  IONS IONIS PHARMACEUTICALS INC | Award(A) Non-Qualified Stock Option (right to buy) | 5,369 | - | - | Direct |
| Jul 1, 2026 | IONS IONIS PHARMACEUTICALS INC | Award(A) Restricted Stock Unit | 2,301 | - | - | Direct |
| Jun 10, 2026 |  PCRX Pacira BioSciences, Inc. | Award(A) | 6,405 | - | $0 | Direct |
| Jan 15, 2026 | IONS IONIS PHARMACEUTICALS INC | Exercise(M) | 1,930 | - | $0 | Direct |
| Jul 15, 2025 | IONS IONIS PHARMACEUTICALS INC | Exercise(M) | 4,079 | - | - | Direct |
| Jul 1, 2025 | IONS IONIS PHARMACEUTICALS INC | Award(A) Non-Qualified Stock Option (right to buy) | 11,518 | - | - | Direct |
| Jul 1, 2025 | IONS IONIS PHARMACEUTICALS INC | Award(A) Restricted Stock Unit | 5,220 | - | - | Direct |
| Jun 11, 2025 | PCRX Pacira BioSciences, Inc. | Award(A) | 6,163 | - | - | Direct |
| Jan 15, 2025 | IONS IONIS PHARMACEUTICALS INC | Exercise(M) | 1,931 | - | $0 | Direct |
1-9 of 9 transactions
About YANG MICHAEL J.
YANG MICHAEL J. (SEC CIK 0001702283) files insider reports with the SEC as Director of IONIS PHARMACEUTICALS INC (IONS) and Director of Pacira BioSciences, Inc. (PCRX).
Signal8 holds 7 ownership filings by YANG MICHAEL J., all Form 4s, filed between Jan 17, 2025 and Jul 6, 2026. Those filings report 9 transactions, from Jan 15, 2025 to Jul 1, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on YANG MICHAEL J.'s filings is in CARLSBAD, CA.
Recent filings by YANG MICHAEL J.
- Jul 1, 2026: Grants or awards of IONS derivative securities (2 lines, Form 4, code A).
- Jun 10, 2026: Grant or award of PCRX shares (Form 4, code A).
- Jan 15, 2026: Option exercise of IONS shares (Form 4, code M).
- Jul 15, 2025: Option exercise of IONS shares (Form 4, code M).
- Jul 1, 2025: Grants or awards of IONS derivative securities (2 lines, Form 4, code A).
Other insiders filing for IONIS PHARMACEUTICALS INC (IONS)
- Devers Shannon L., EVP, Chief Human Resources Ofc
- Swayze Eric, EVP Research
- BENNETT C FRANK, EVP, Chief Scientific Officer
- O'NEIL PATRICK R., EVP CLO & General Counsel
- Monia Brett P, Chief Executive Officer
- Birchler Brian, EVP, Corp and Development Ops